Raising Threshold for Diagnosis of Polycystic Ovary Syndrome Excludes Population of Patients with Metabolic Risk

    July 2016 in “ Fertility and Sterility ”
    Molly Quinn, Chia-Ning Kao, Asima Ahmad, Nikolaus Lenhart, Kanade Shinkai, Marcelle I. Cedars, Heather G. Huddleston
    Image of study
    TLDR Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.
    The study, conducted on 259 women diagnosed with PCOS and 1,100 controls, found that increasing the follicle number threshold for PCOS diagnosis to ≥25 would exclude 18.1% of women who still exhibit metabolic risks. The excluded women showed clinical and biochemical signs of hyperandrogenism and had higher levels of total cholesterol, fasting insulin, and insulin resistance compared to controls. The findings suggest that the proposed diagnostic criteria may overlook women with significant metabolic dysfunction, indicating a need to reevaluate the criteria to ensure that all women at risk for PCOS and its associated metabolic complications are accurately identified and managed.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 6 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results